title: Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons.
abstract: OBJECTIVE
  To evaluate the usefulness of one of IGRAs, QuantiFERON-TB Gold (QFT-G), in human immunodeficiency virus- (HIV-) infected patients with various CD4(+) T cell counts.
  
  
  METHODS
  The QFT-G assay was performed using QFT-G kits among 107 HIV-infected patients including 9 cases with active tuberculosis (TB).
  
  
  RESULTS
  In HIV-infected patients with CD4(+) > 50/microL, QFT-G positive rate for active TB patients was 5/6 (sensitivity = 83%), and that for those without active disease was 1/69 (specificity = 99%). The frequency of indeterminate QFT-G test was significantly higher in those with CD4(+) less than 50/microL (P < .0001). At the same time there was a proportional relationship between CD4(+) and interferon-gamma response to mitogen (positive control) in QFT-G test (P = .0001). Conclusions. Our data suggested that QFT-G had high sensitivity and specificity in HIV-infected populations with CD4(+) greater than 50/microL. However, QFT-G did not perform well in HIV-positive patients with CD4(+) less than 50/microL.
authors.affiliation: Department of Pulmonary Medicine, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu-shi, Tokyo 183-8524, Japan. akira_fujita@tmhp.jp
authors.forename: Akira
authors.initials: A
authors.lastname: Fujita
authors.forename: Atsushi
authors.initials: A
authors.lastname: Ajisawa
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Harada
authors.forename: Kazue
authors.initials: K
authors.lastname: Higuchi
authors.forename: Toru
authors.initials: T
authors.lastname: Mori
mesh_terms: D000328:Adult; D000368:Aged; D000942:Antigens, Bacterial / Q000276:immunology*; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000150:complications*; D006801:Humans; D007159:Immunologic Tests / Q000379:methods*; D007371:Interferon-gamma / Q000096:biosynthesis / Q000097:blood*; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000276:immunology; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity; D014374:Tuberculin Test; D014376:Tuberculosis / Q000097:blood / Q000150:complications* / Q000175:diagnosis*; D055815:Young Adult
chemical_list: D000942:Antigens, Bacterial; D011933:Reagent Kits, Diagnostic; D007371:Interferon-gamma
references.citation: MMWR Recomm Rep. 1998 Oct 30;47(RR-20):1-58
references.pmid: 9809743
references.citation: MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51
references.pmid: 10881762
references.citation: Kekkaku. 2004 Dec;79(12):725-35
references.pmid: 15782618
references.citation: Clin Infect Dis. 1993 Dec;17(6):968-75
references.pmid: 8110954
references.citation: MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4
references.pmid: 19357635
references.citation: MMWR Recomm Rep. 2005 Dec 16;54(RR-15):49-55
references.pmid: 16357824
references.citation: Kekkaku. 1960 Aug;35:563-6
references.pmid: 13765102
references.citation: Kekkaku. 2006 May;81(5):393-7
references.pmid: 16886264
references.citation: Am J Respir Crit Care Med. 2007 Apr 1;175(7):737-42
references.pmid: 17218620
references.citation: Kekkaku. 2007 Aug;82(8):635-40
references.pmid: 17874571
references.citation: J Infect Chemother. 2009 Jun;15(3):143-55
references.pmid: 19554399
references.citation: Lancet. 2000 Sep 23;356(9235):1099-104
references.pmid: 11009160
references.citation: Lancet Infect Dis. 2007 Jun;7(6):428-38
references.pmid: 17521596
references.citation: Jpn J Infect Dis. 2005 Dec;58(6):S19-21
references.pmid: 16377859
references.citation: BMC Infect Dis. 2009 Feb 10;9:15
references.pmid: 19208218
references.citation: Clin Infect Dis. 2009 Apr 1;48(7):954-62
references.pmid: 19245343
references.citation: Respir Res. 2006 Apr 01;7:56
references.pmid: 16579856
references.citation: J Infect. 2008 May;56(5):348-53
references.pmid: 18395264
references.citation: Infect Immun. 1996 Jan;64(1):16-22
references.pmid: 8557334
references.citation: Expert Rev Mol Diagn. 2009 Mar;9(2):165-77
references.pmid: 19298140